Reverse transcription-quantitative (RT-q) PCR showed that all the 15 glioma samples' PANTR1 expression outweighs normal adjacent tissues, whereas grade II and III glioma tend to have a higher expression rather than GBM compared with NAT (supplement 10). The gene discussed is BRD2; the disease is glioblastoma.